Skip to content

Effect of Sarcopenia on Clinical Outcome of Total Knee Arthroplasty

Effect of Sarcopenia on Clinical Outcome of Total Knee Arthroplasty

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06136039
Enrollment
150
Registered
2023-11-18
Start date
2022-06-03
Completion date
2024-12-31
Last updated
2024-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

As human life expectancy increases, the prevalence of degenerative osteoarthritis of the knee joints is steadily rising, leading to a significant surge in the frequency of total knee arthroplasty (TKA). However, research on sarcopenia in the population that comprises the primary recipients of these orthopedic joint surgeries has been notably lacking. Since the release of the 2019 Consensus update on sarcopenia by the Asian Walking Group for Sarcopenia (AWGS) in 2020, research on sarcopenia has gained momentum in various domains. Yet, as previously mentioned, the field of orthopedics still lags behind in investigating sarcopenia. Therefore, it is believed that establishing the relationship between sarcopenia and surgical outcomes in the elderly, who are the primary targets of orthopedic joint replacement surgery, could offer insights to further enhance the results of joint replacement surgeries.

Interventions

PROCEDUREArm I (Sarcopenia)

Same as standard treatment

PROCEDUREArm II(Normal)

Same as standard treatment

Sponsors

Gangnam Severance Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This study has prospective cohort design. Prior to surgery, a sarcopenia assessment was conducted to categorize patients into sarcopenia and normal groups. Sarcopenia was reassessed at 6 and 12 months post-surgery for comparison with the preoperative state. Additionally, clinical outcomes of patients were evaluated at 3, 6, and 12 months post-surgery for comparison between the normal and sarcopenia groups.

Eligibility

Sex/Gender
FEMALE
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* A woman aged 60 or older who is undergoing TKA due to degenerative osteoarthritis of the knee joint at the our institution.

Exclusion criteria

1. Male 2. Under 60 years of age 3. Patients with a history of rheumatoid arthritis, traumatic joint disease, and post-infection joint disease 4. Patients who cannot undergo tests for muscle weakness diagnosis A. Patients unable to walk B. Patients unable to stand alone due to conditions like cerebral palsy or brain disorders C. Patients unable to use muscle strength 5. Patients considered inappropriate for recruitment in this study based on the judgment of the research team.

Design outcomes

Primary

MeasureTime frameDescription
ASM6, 12months after surgeryAppendicular Skeletal Muscle Mass was measured through Bioelectrical Impedance Analysis.
handgrip strength, gait speed, SPPB, ASM)6, 12months after surgeryHandgrip strengths were measured using a handgrip dynamometer before surgery. low muscle mass AND (low physical performance OR low strength) : sarcopenia low muscle mass AND (low physical performance AND low strength) : severe sarcopenia
gait speed6, 12months after surgeryGait speed was measured using a dedicated camera equipped with LiDAR sensors.
SPPB6, 12months after surgeryThe Short Physical Performance Battery was measured using a dedicated device that included a force plate.

Secondary

MeasureTime frameDescription
Knee Society Score3, 6, and 12months after surgeryThe original KSS has a Knee Score section (7 items) and a Functional Score section (3 items). Both sections are scored from 0 to 100 with lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions
WOMAC3, 6, and 12months after surgeryHigher scores indicate worse pain, stiffness, and functional limitations. The WOMAC measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68).
EQ-5D3, 6, and 12months after surgeryThe EuroQol 5 Dimension (EQ-5D) is a self-report survey that measures quality of life across 5 domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression
UCLA score3, 6, and 12months after surgeryThe UCLA Activity Scale (UCLA) is a questionnaire assessing physical activity level from 1 (low) to 10 (high) in patients undergoing hip or knee arthroplasty

Countries

South Korea

Contacts

Primary ContactByungwoo Cho
gsirb@yuhs.ac82-2-2019-3419

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026